Article
Inhibition of skin development by targeted expression of a dominant-negative retinoic acid receptor.
Nature - 9 Mar 1995
Saitou M, Sugai S, Tanaka T, Shimouchi K, Fuchs E, Narumiya S, Kakizuka A
Abstract excerpt
Although pharmacological doses of retinoic acid (RA) have a wide variety of actions in vivo, experimental difficulties have prevented a definitive assignment of its physiological functions. We recently made a dominant-negative retinoic acid receptor (RAR) by a single amino-acid substitution which creates a dominant-negative thyroid hormone receptor. The mutated RAR efficiently inhibited the endogenous activities...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
